Novocure

NVCR • NASDAQ •
Overview Stats Financials News

Yahoo Finance • 10 days ago

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

Durable survival effect observed in the largest prospective, non-interventional study completed examining TTFields therapy use in newly diagnosed GBM Topline data to be presented Saturday, June 1, 2024 at the 2024 American Society of Clin... Full story

Yahoo Finance • 5 months ago

Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer

ROOT, Switzerland, January 04, 2024--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced the appointment of Nicolas Leupin, M.D., Ph.D., MBA to the role of Chief Medical Officer. Dr. Leupin brings a proven track record of leadership a... Full story

Yahoo Finance • 5 months ago

Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference

ROOT, Switzerland, December 27, 2023--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024. William Doyle, Novocure’s Executive... Full story

Yahoo Finance • 7 months ago

11 Best Undervalued UK Stocks To Buy Now

In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now. If you want to skip our overview of the British economy, then take a look at 5 Best Undervalued UK Stocks To Buy Now. The U.K. is one of the biggest eco... Full story

Yahoo Finance • 7 months ago

Novocure Reports Third Quarter 2023 Financial Results

Quarterly net revenues of $127 million with 3,639 active patients on therapy as of September 30, 2023 ROOT, Switzerland, October 26, 2023--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended Sep... Full story

Yahoo Finance • 8 months ago

NovoCure (NASDAQ:NVCR investor three-year losses grow to 90% as the stock sheds US$229m this past week

As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of NovoCure Limited (NASDAQ:NVCR) investors who have... Full story

Yahoo Finance • 9 months ago

Lifshitz Law PLLC Announces Investigations of Peloton Interactive, Inc. (NASDAQ: PTON), DZS Inc. (NASDAQ: DZSI), TriplePoint Venture Growth BDC Corp. (NYSE: TPVG), and NovoCure Ltd. (NASDAQ: NVCR)

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations... Full story

Yahoo Finance • 9 months ago

Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer

Novocure said Monday its cancer treatment failed to make a difference for ovarian cancer patients, and NVCR stock plummeted. Continue reading... Full story

Yahoo Finance • 9 months ago

Could NovoCure Stock Help You Become a Millionaire?

One mid-cap stock that could have significant upside is healthcare company NovoCure (NASDAQ: NVCR), which makes tumor treating fields (TTF) devices. There are some exciting ongoing studies in the company's pipeline that could make it a hot... Full story

Yahoo Finance • 9 months ago

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover l... Full story

Yahoo Finance • 10 months ago

DEADLINE ALERT for NVCR, TIGR, GDS, AROW, IBRX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 10 months ago

NVCR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 18, 2023 in the Class Action Filed on Behalf of NovoCure Limited Shareholders

NEW YORK, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR) alleging that the Company violated federal securities laws... Full story

Yahoo Finance • 10 months ago

FRIDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Case – NVCR

SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NovoCure Limited (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023, all dates inclusive (the “Class... Full story

Yahoo Finance • 10 months ago

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NovoCure Investors of a Lead Plaintiff Deadline of August 18, 2023

NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Attention NovoCure Limited ("NovoCure") (NASDAQ: NVCR) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased bet... Full story

Yahoo Finance • 10 months ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)

LOS ANGELES, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased... Full story

Yahoo Finance • 10 months ago

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover l... Full story

Yahoo Finance • 10 months ago

Calling all investors in NovoCure Limited (NVCR): New lawsuit lead plaintiff deadline is August 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NovoCure Limited (“NovoCure”... Full story

Yahoo Finance • 10 months ago

DEADLINE ALERT for DZSI, and NVCR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story

Yahoo Finance • 10 months ago

NVCR DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of NovoCure Limited (NASDAQ: NVCR)?Did you purchase your shares between January 5, 2023 and June 5, 2023, inclusive? Did you lose money... Full story

Yahoo Finance • 10 months ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DZS, TriplePoint, NovoCure, and UP Fintech and Encourages Investors to Contact the Firm

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DZS, Inc. (NASDAQ: DZSI),... Full story